News from CROI 2015

The annual Conference on Retroviruses and Opportunistic Infections (CROI 2015) is taking place in Seattle, USA, in late February.

Our writers will be reporting on key research presented at the conference, publishing news and sending out CROI news summary bulletins by email, three during the conference week and one the following week.

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

aidsmap news from CROI 2015

Inflammation and gut leakage remains elevated in people with HIV despite early antiretroviral treatment

Inflammatory changes and damage to the gut begin very soon after initial HIV infection, and may not return to normal even when people start antiretroviral therapy (ART)

Published
16 March 2015
By
Liz Highleyman
Screening may miss pre-cancerous anal lesions in women with HIV

Existing algorithms to screen for anal cancer in women living with HIV could be missing many cases of anal high-grade squamous intraepithelial lesions (HSIL) – abnormal tissue

Published
12 March 2015
By
Theo Smart
Re-infection due to ongoing risk probably the cause of HCV recurrence after SVR

Rates of hepatitis C virus (HCV) reoccurrence after successful therapy differ markedly between risk groups, according to the results of a meta-analysis presented at the recent Conference on

Published
11 March 2015
By
Michael Carter
Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people

People with HIV and hepatitis C virus (HCV) co-infection who take sofosbuvir/ledipasvir (Harvoni) to treat hepatitis C along with boosted protease inhibitor antiretroviral regimens may experience changes

Published
10 March 2015
By
Liz Highleyman
Studies offer mounting evidence that statins may reduce the risk of heart disease in people living with HIV

Evidence is mounting that statin therapy can prevent the progression of coronary atherosclerosis (hardening and narrowing of the arteries supplying the heart) in people living with HIV, according

Published
10 March 2015
By
Theo Smart
We may need to combine many approaches to achieve a cure, delegates hear

It is unlikely that one single approach will achieve a cure for HIV infection, delegates at a community cure workshop held the day before the Conference on

Published
09 March 2015
By
Gus Cairns
Does HIV make you fat? Study connects viral load with fat gains

HIV infection, or inflammatory changes associated with it, may be responsible for fat accumulation and body fat redistribution, rather than HIV drugs, the Conference on Retroviruses and

Published
06 March 2015
By
Gus Cairns
Screening study finds high prevalence of early-stage lung cancer among smokers with HIV

Using low-dose computed tomography to screen selected people living with HIV who smoke, led to early lung cancer diagnoses at younger ages than normally seen in the

Published
05 March 2015
By
Theo Smart
Smoking is the biggest risk factor for non-AIDS-defining cancers in people living with HIV

Smoking appears to contribute most to the burden of non-AIDS-defining cancers diagnosed in people living with HIV in the US, out of all the potential modifiable risk

Published
04 March 2015
By
Theo Smart
Varenicline helps people with HIV stop smoking, but success rate remains low

The smoking cessation drug varenicline (Champix, or Chantix in the United States) helped more people with HIV to stop smoking than counselling alone, but less than 20%

Published
04 March 2015
By
Liz Highleyman
← Prev12345Next →

Email bulletins

Sign up for our conference bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.